Anionic Amino Acid Dendrimer−Trastuzumab Conjugates for Specific Internalization in HER2-Positive Cancer Cells-Reference-Cited by-同舟云学术

Anionic Amino Acid Dendrimer−Trastuzumab Conjugates for Specific Internalization in HER2-Positive Cancer Cells

Published:2010-06-18 Issue:4 Volume:7 Page:1318-1327
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Miyano Takuya¹,Wijagkanalan Wassana¹,Kawakami Shigeru¹,Yamashita Fumiyoshi¹,Hashida Mitsuru¹

Affiliation:

1. Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan, Japan Society for the Promotion of Science, Chiyoda-ku, Tokyo 102-8471, Japan, and Institute of Integrated Cell-Material Sciences, Kyoto University, Kyoto 606-8501, Japan

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp100105c

Reference51 articles.

1. Monoclonal antibody therapy of cancer

2. Monoclonal antibodies as therapeutic agents for cancer

3. Development trends for new cancer therapeutics and vaccines

4. ErbB Receptors: Directing Key Signaling Networks Throughout Life

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacoproteomics and Drug Delivery Strategies for Cancer Nanomedicines;Pharmacoproteomics;2024

2. Dendrimer-based nanomedicines for cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024

3. Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications;Critical Reviews™ in Therapeutic Drug Carrier Systems;2024

4. Amine-terminated dendrimers: A novel method for diagnose, control and treatment of cancer;Cancer Epigenetics and Nanomedicine;2024

5. Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery;Biomaterials Research;2023-05-06